Weight-loss drugs aren’t just slimming waists. They’re shifting the economy.

Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so significant it could shift GDP.

View original article
Contributor: Ariana Eunjung Cha